132 related articles for article (PubMed ID: 34320515)
1. Pre-existing chronic kidney disease and hypertension increased the risk of cardiotoxicity among colorectal cancer patients treated with anticancer drugs.
Ho CC; Wen PC; Yu WC; Hu YW; Yang CC
J Chin Med Assoc; 2021 Sep; 84(9):877-884. PubMed ID: 34320515
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers.
Nhola LF; Abdelmoneim SS; Villarraga HR; Kohli M; Grothey A; Bordun KA; Cheung M; Best R; Cheung D; Huang R; Barros-Gomes S; Pitz M; Singal PK; Jassal DS; Mulvagh SL
J Am Soc Echocardiogr; 2019 Feb; 32(2):267-276. PubMed ID: 30459123
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
Henry ML; Niu J; Zhang N; Giordano SH; Chavez-MacGregor M
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1084-1093. PubMed ID: 30092967
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
5. Cancer Therapy-Related Cardiotoxicity: A Comprehensive Retrospective Analysis at Najran Cancer Center, Saudi Arabia.
Badheeb AM; Ahmed F; Alzahrani HA; Badheeb MA; Obied HY; Seada IA
Cureus; 2023 Jul; 15(7):e41287. PubMed ID: 37533611
[TBL] [Abstract][Full Text] [Related]
6. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer.
Tong L; Ahn C; Symanski E; Lai D; Du XL
Ann Oncol; 2014 Jun; 25(6):1234-42. PubMed ID: 24681607
[TBL] [Abstract][Full Text] [Related]
7. Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement.
Jämsä P; Jämsen E; Huhtala H; Eskelinen A; Oksala N
Clin Orthop Relat Res; 2018 Jun; 476(6):1284-1292. PubMed ID: 29601379
[TBL] [Abstract][Full Text] [Related]
8. Second-line systemic therapy for metastatic colorectal cancer.
Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent differences in first-line chemotherapy in patients with metastatic colorectal cancer: the DISCO study.
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
Acta Oncol; 2018 Nov; 57(11):1445-1454. PubMed ID: 30375911
[TBL] [Abstract][Full Text] [Related]
10. Association Between Use of Anticancer Drugs and Cardiovascular Disease-Related Hospitalization in Metastatic Colorectal Cancer: Insights From a Population-Based Study, the Anticancer Vigilance of Cardiac Events Study.
Dolladille C; Launoy G; Bouvier V; Salem JE; Legallois D; Milliez P; Sassier M; Lobbedez T; Guittet L; Alexandre J
Am J Epidemiol; 2021 Feb; 190(3):376-385. PubMed ID: 32964219
[TBL] [Abstract][Full Text] [Related]
11. Preventing cancer therapy-related heart failure: the need for novel studies.
Fogarassy G; Vathy-Fogarassy Á; Kenessey I; Veress G; Polgár C; Forster T
J Cardiovasc Med (Hagerstown); 2021 Jun; 22(6):459-468. PubMed ID: 32941327
[TBL] [Abstract][Full Text] [Related]
12. CARDIOTOXICITY RISK PREDICTION IN BREAST CANCER PATIENTS.
Kozhukhov SM; Dovganych NV; Smolanka II; Lygyrda OF; Bazyka OY; Lyalkin SA; Ivankova OM; Yarinkina OA; Tkhor NV
Probl Radiac Med Radiobiol; 2021 Dec; 26():498-512. PubMed ID: 34965569
[TBL] [Abstract][Full Text] [Related]
13. Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis.
Batist G; Harris L; Azarnia N; Lee LW; Daza-Ramirez P
Anticancer Drugs; 2006 Jun; 17(5):587-95. PubMed ID: 16702817
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
[No Abstract] [Full Text] [Related]
15. Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study.
Huang WW; Hsieh KP; Huang RY; Yang YH
Kaohsiung J Med Sci; 2017 Jun; 33(6):308-314. PubMed ID: 28601236
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer.
Lee CH; Zhang JF; Yuan KS; Wu ATH; Wu SY
Strahlenther Onkol; 2019 Jul; 195(7):629-639. PubMed ID: 30690687
[TBL] [Abstract][Full Text] [Related]
17. Risk of colorectal cancer after the diagnosis of prostate cancer: A population-based study.
Desautels D; Czaykowski P; Nugent Z; Demers AA; Mahmud SM; Singh H
Cancer; 2016 Apr; 122(8):1254-60. PubMed ID: 26919270
[TBL] [Abstract][Full Text] [Related]
18. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
19. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
Kim JW; Lee KW; Kim KP; Lee JH; Hong YS; Kim JE; Kim SY; Park SR; Nam BH; Cho SH; Chung IJ; Park YS; Oh HS; Lee MA; Kang HJ; Park YI; Song EK; Han HS; Lee KT; Shin DB; Kang JH; Zang DY; Kim JH; Kim TW
Oncologist; 2017 Mar; 22(3):293-303. PubMed ID: 28209749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]